Skip to main content

Table 2 Characteristics of patients from transplant haematology ward infected with CoNS displaying reduced susceptibility to glycopeptides

From: Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options

Pat. Age Underlying disease Antimicrobial prophylaxis Neutrophyl count/mm3 Days from transplantation Immuno-suppression Therapy Catheter removal CR-BSI Micro-biological eradication
1 29 ALL no 2300 43 ciclosporin linezolid-pip/tazo-amika no ? yes
2 40 MM no 1380 128 ciclosporin teicoplanin-pip/tazo-amika no ? yes
3 34 AML levofloxacin 10 9 no linezolid-pip/tazo-amika yes yes yes
4 20 HD no 6200 3 no teicoplanin-pip/tazo-amika no ? yes
5 52 NHL levofloxacin 10 5 no teicoplanin-pip/tazo-amika yes yes yes
6 54 ALL no 1000 3 ciclosporin teicoplanin yes yes yes
7 58 MM no 3700 30 no teicoplanin-pip/tazo-amika yes yes yes
  1. ALL = acute lymphocitic leukaemia; AML = acute myeloid leukaemia; MM = multiple myeloma; HD = Hodgkin's disease; NHL = non-Hodgkin's lymphoma; MUD = matched unrelated donor; pip/tazo = piperacillin/tazobactam; amika = amikacin; CR-BSI = catheter related blood stream infection; ? = not confirmed